MX2009008525A - La determinacion cuantitativa de risedronato en orina mediante spe-lc-ms-ms. - Google Patents

La determinacion cuantitativa de risedronato en orina mediante spe-lc-ms-ms.

Info

Publication number
MX2009008525A
MX2009008525A MX2009008525A MX2009008525A MX2009008525A MX 2009008525 A MX2009008525 A MX 2009008525A MX 2009008525 A MX2009008525 A MX 2009008525A MX 2009008525 A MX2009008525 A MX 2009008525A MX 2009008525 A MX2009008525 A MX 2009008525A
Authority
MX
Mexico
Prior art keywords
spe
risedronate
urine
quantitative determination
directed
Prior art date
Application number
MX2009008525A
Other languages
English (en)
Inventor
Liduo Shen
Yongyi Luo
Original Assignee
Sanofi Aventis Us Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis Us Llc filed Critical Sanofi Aventis Us Llc
Publication of MX2009008525A publication Critical patent/MX2009008525A/es

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/52—Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/16—Phosphorus containing
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/16—Phosphorus containing
    • Y10T436/166666—Phosphorus containing of inorganic phosphorus compound in body fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

La presente invención se refiere a un método de SPE-LC-MS-MS para determinar cuantitativamente el risedronato en una muestra de orina.
MX2009008525A 2007-03-07 2008-03-05 La determinacion cuantitativa de risedronato en orina mediante spe-lc-ms-ms. MX2009008525A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US89344407P 2007-03-07 2007-03-07
PCT/US2008/055849 WO2008109632A1 (en) 2007-03-07 2008-03-05 The quantitative determination of risedronate in urine by spe-lc-ms-ms

Publications (1)

Publication Number Publication Date
MX2009008525A true MX2009008525A (es) 2009-08-27

Family

ID=39400853

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009008525A MX2009008525A (es) 2007-03-07 2008-03-05 La determinacion cuantitativa de risedronato en orina mediante spe-lc-ms-ms.

Country Status (16)

Country Link
US (2) US8168437B2 (es)
EP (1) EP2132567A1 (es)
JP (1) JP5352479B2 (es)
KR (1) KR20090125764A (es)
CN (1) CN101657722A (es)
AR (1) AR065598A1 (es)
AU (1) AU2008222912B2 (es)
BR (1) BRPI0808416A2 (es)
CA (1) CA2680183C (es)
IL (1) IL200697A0 (es)
MX (1) MX2009008525A (es)
MY (1) MY149500A (es)
RU (1) RU2467332C2 (es)
SG (1) SG179447A1 (es)
TW (1) TW200902975A (es)
WO (1) WO2008109632A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5193266B2 (ja) * 2010-11-16 2013-05-08 株式会社ミノファーゲン製薬 生薬由来成分の高感度定量方法
RU2469315C1 (ru) * 2011-05-13 2012-12-10 Федеральное государственное автономное образовательное учреждение высшего профессионального образования "Белгородский государственный национальный исследовательский университет" Способ количественного определения органических соединений
CN102735788B (zh) * 2012-07-11 2014-10-22 中国检验检疫科学研究院 样品中羟乙磷酸及其盐类的分析测定方法
CN103063776A (zh) * 2012-12-29 2013-04-24 国家烟草质量监督检验中心 一种柱转换测定尿液中cema和hema含量的方法
CN104062381A (zh) * 2014-07-11 2014-09-24 陕西汉江药业集团股份有限公司 一种双膦酸类化合物的含量测定方法
CN105223264B (zh) * 2015-09-21 2017-12-29 广东联捷生物科技有限公司 一种质谱定量分析的模拟内标方法、装置及应用
CN110308217A (zh) * 2019-05-21 2019-10-08 北京九昊医药科技有限公司 基于lc-ms/ms前衍生化测定人血浆中利塞膦酸的方法及其应用
CN114113379A (zh) * 2021-11-12 2022-03-01 四川尚锐分析检测有限公司 一种采用lc-ms法检测血浆中伊班磷酸钠的方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3774888B2 (ja) * 2001-11-28 2006-05-17 日本化薬株式会社 ステロイド類化合物のｌｃ−ｍｓによる高感度検出法
JP2006112835A (ja) * 2004-10-12 2006-04-27 Maruishi Pharmaceutical Co Ltd デクスメデトミジンの定量方法
WO2006127973A2 (en) * 2005-05-24 2006-11-30 Waters Inverstments Limited Methods for separating and analyzing anionic compounds

Also Published As

Publication number Publication date
US20090320572A1 (en) 2009-12-31
BRPI0808416A2 (pt) 2014-07-22
RU2467332C2 (ru) 2012-11-20
US20120193528A1 (en) 2012-08-02
JP5352479B2 (ja) 2013-11-27
AU2008222912A1 (en) 2008-09-12
CA2680183A1 (en) 2008-09-12
CA2680183C (en) 2012-10-09
JP2010520489A (ja) 2010-06-10
RU2009136989A (ru) 2011-04-20
MY149500A (en) 2013-09-13
WO2008109632A1 (en) 2008-09-12
US8168437B2 (en) 2012-05-01
CN101657722A (zh) 2010-02-24
IL200697A0 (en) 2010-05-17
TW200902975A (en) 2009-01-16
AR065598A1 (es) 2009-06-17
SG179447A1 (en) 2012-04-27
KR20090125764A (ko) 2009-12-07
EP2132567A1 (en) 2009-12-16
AU2008222912B2 (en) 2013-05-02

Similar Documents

Publication Publication Date Title
MX2009008525A (es) La determinacion cuantitativa de risedronato en orina mediante spe-lc-ms-ms.
EA201600085A1 (ru) Набор для обнаружения соевого события syht0h2
IL225386A (en) A method for identifying cancer by identifying ereg protein
EP2047268A4 (en) INDICATOR SYSTEM FOR DETERMINING ANALYTE CONCENTRATION
IN2013CN01129A (es)
TN2013000464A1 (en) Biomarkers for hedgehog inhibitor therapy
WO2008033575A3 (en) Methods of identifying biochemical pathways
AU2012356133A8 (en) A rapid quantitative assay to measure CFTR function in a primary intestinal culture model
EA201390762A1 (ru) Новые биомаркеры для предсказания исхода противораковой иммунотерапии
GB0805814D0 (en) Biosensor for analyte detection
MX357429B (es) Predictores para el tratamiento del cáncer.
EP2247933A4 (en) METHODS AND KITS FOR DETERMINING THE PRESENCE AND QUANTITY OF VITAMIN D ANALOGUES IN SAMPLE
EA201171178A1 (ru) Устройство и способ для определения и количественного анализа аналитов, в частности, микотоксинов
BRPI0820876B8 (pt) método para determinação da quantidade de estrona em uma amostra de fluido corporal
ATE504002T1 (de) Erkennung und vorhersage von frühgeburten
MX2010008496A (es) Metodo para la determinacion de sensibilidad a agente anticancerigeno.
HK1133295A1 (en) Use of protein s100a12 as a marker for colorectal cancer s100a12
EP2062052A4 (en) METHOD FOR DETERMINING ANALYZ CONCENTRATION
CA2839777C (en) Methods for the prognostic and/or diagnostic of neurodegenerative disease, methods to identify candidate compounds and compounds for treating neurodegenerative disease
ZA200704159B (en) Method for analysis of pellet-cladding interaction
EP2075341A4 (en) METHOD FOR THE INVESTIGATION, DETERMINATION OR EVALUATION BY MEANS OF GENE EXPRESSION ANALYSIS
MX336940B (es) Uso de compuestos mejoradores de señal en deteccion de electroquimioluminiscencia.
ATE519116T1 (de) Verfahren zur normierung der konzentration von analyten in einer urinprobe
EP2058656A4 (en) REAGENT FOR BLEIKONZENTRATIONBESTIMMUNG AND METHOD FOR BLEIKONZENTRATIONSBESTIMMUNG
WO2012145516A3 (en) Methods and kits for quantitative determination of total organic acid content in a coolant

Legal Events

Date Code Title Description
HH Correction or change in general
FG Grant or registration